期刊文献+

药物涂层球囊临床应用中国专家共识 被引量:202

下载PDF
导出
摘要 经皮冠状动脉介入治疗(percutaneous coronary intervention,PCI)已经成为冠心病治疗的主要手段。近10年来,我国冠心病PCI例数保持15%~20%的年均增长率~[1]。而随着支架使用数量的增加,支架内再狭窄(in-stent restenosis,ISR)问题日益严重。
出处 《中国介入心脏病学杂志》 2016年第2期61-67,共7页 Chinese Journal of Interventional Cardiology
  • 相关文献

参考文献47

  • 1葛均波.开拓新兴介入技术 发展多元介入治疗[J].中国介入心脏病学杂志,2013,21(1):1-1. 被引量:17
  • 2Kastrati A, Schfimig A, Elezi S, et al. Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol, 1997, 30(6) : 1428-1456.
  • 3Laham R J, Carrozza JP, Berger C, et al. Long-term ( 4-to 6- year) outcome of Palmaz-Schatz stenting: paucity of late clinical stent-related problems. J Am Coil Cardiol, 1996, 28 ( 4 ) : 820- 826.
  • 4卢长林,郭炜华,杨跃进,高润霖.冠状动脉支架内再狭窄的现状与展望[J].中国心血管杂志,2012,17(6):409-412. 被引量:26
  • 5Scheller B, Speck U, Abramjuk C, et al. Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis. Circulation, 2004, 110(7) : 810-814.
  • 6Sergie Z, Dangas GD. In-stent restenosis of bifurcation lesions: experience with drug-eluting balloons. Catheter Cardiovasc Interv, 2012, 79 ( 3 ) :397-398.
  • 7付强,苗志林,李占全.药物洗脱球囊的研究进展[J].中国介入心脏病学杂志,2011,19(2):111-113. 被引量:11
  • 8Cremers B, Toner JL, Schwartz LB, et al. Inhibition of neointimal hyperplasia with a novel zotarolimus coated balloon catheter. Clin Res Cardiol, 2012, 101(6) :469-476.
  • 9Loh JP, Barbash IM, Waksman R. The current status of drug- coated balloons in percutaneous coronary and peripheral interventions. EuroIntervention, 2013, 9(8) :979-988.
  • 10周忠江,侯玉清.药物涂层球囊在冠状动脉介入治疗中的应用进展[J].中国介入心脏病学杂志,2014,22(3):191-194. 被引量:20

二级参考文献53

  • 1Maisel WH.Unanswered questions:drug-eluting stents and the risk of late thrombosis.N Engl J Med,2007,356:981-984.
  • 2Lemos PA,Hoye A,Coedhart D,et al.Clinical,angiographic,and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients:an evaluation from the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) study.Circulation,2004,109:1366-1370.
  • 3Iofina E,Langenberg R,Blindt R,et al.Polymer-based paclitaxel-eluting stents are superior to nonpolymer-based paclitaxeleluting stents in the treatment of de novo coronary lesions.Am J Cardiol,2006,98:1022-1027.
  • 4Van der Giessen WJ,Lincoff AM,Schwartz RS,et al.Marked inflammatory sequelaeto implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries.Circulation,1996,94:1690-1697.
  • 5Goldman B,Blanke H,Wolinsky H.Influence of pressure on permeability of normal and diseased muscular arteries to horseradish peroxidase:a new catheter approach.Atherosclerosis,1987,6:215-225.
  • 6Scheller B,Speck U,Romeike B.Contrast media as carriers for local drug delivery successful inhibition of neointimal proliferation in the porcine coronary stent model.Eur Heart J,2003,24:1462-1467.
  • 7Oberhoff M,Kunert W,Herdeg C,et al.Inhibition of smooth muscle cell proliferation after local drug delivery of the antimitotic drug paclitaxel using a porus balloon catheter.Basic Res Cardiol,2001,96:275-282.
  • 8Cremers B,speck U,Kaufels N,et al.Drug-eluting balloon:very short-term exposure and overlapping.Thromb Haemost,2009,101:201-206.
  • 9Scheller B,Speck R,Abramjuk I,et al.Pacliaxel balloon coating,a novel method for prevention and therapy of restenosis.Circulation,2004,110:810-814.
  • 10Speck U,Scheller B,Abramjuk C.Neointima inhibition:comparison of effectiveness of non-stent-based local drug delivery and a drug-eluting stent in porcine coronary arteries.Radiology,2006,240:411-418.

共引文献64

同被引文献670

引证文献202

二级引证文献654

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部